Literature DB >> 6728560

Low antithrombin III levels in neonates with idiopathic respiratory distress syndrome: poor prognosis.

M Peters, J W Ten Cate, C Breederveld, R De Leeuw, J Emeis, J Koppe.   

Abstract

Automated microanalytic chromogenic coagulation assays allow serial monitoring of critically ill newborn infants. In this study 84 premature infants [26 healthy prematures and 58 neonates with idiopathic respiratory distress syndrome (IRDS)] were studied daily during the first week of life, to investigate the possible significance of hemostatic abnormalities in IRDS. In neonates with IRDS, coagulation factors II and X, antithrombin III (AT-III), plasminogen, and alpha 2-antiplasmin were significantly lower than control values. Recovery of the initially low AT-III levels was delayed relative to the other coagulation parameters measured. An AT-III less than or equal to 0.15 U/ml was present within the first 6 h of life in eight patients who developed IRDS, seven of whom died within 48 h. Autopsy of these neonates showed widespread fibrin deposition and hemorrhage in vital organs consistent with intravascular coagulation. These findings indicate that very low levels of AT-III are associated with disseminated intravascular coagulation in neonates with IRDS and suggest that a deficiency of AT-III is predictive of a poor outcome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6728560     DOI: 10.1203/00006450-198403000-00012

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Ligand-dependent enhancement of human antithrombin gene expression by retinoid X receptor alpha and thyroid hormone receptor beta.

Authors:  R W Niessen; F Rezaee; P H Reitsma; M Peters; J J de Vijlder; A Sturk
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

2.  Antithrombin III Supplementation in a Premature Infant: Is There a Target Antithrombin Level?

Authors:  Ankit Shukla; Chi Braunreiter
Journal:  J Pediatr Pharmacol Ther       Date:  2021-11-10

3.  Low antithrombin III in neonatal shock: DIC or non-specific protein depletion?

Authors:  B K Schmidt; T Muraji; A Zipursky
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

4.  Low antithrombin III: accurate predictor of idiopathic respiratory distress syndrome in premature neonates.

Authors:  W van den Berg; C Breederveld; J W ten Cate; M Peters; J J Borm
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

5.  Antithrombin III in children with various renal diseases.

Authors:  H Fukui; A Taniguchi; S Sakamoto; S Kawahara; T Matsunaga; K Taira; S Tanaka; H Kamitsuji
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

6.  Plasma proteomics reveals gestational age-specific responses to mechanical ventilation and identifies the mechanistic pathways that initiate preterm lung injury.

Authors:  Prue M Pereira-Fantini; Sean G Byars; Karen E McCall; Elizabeth J Perkins; Regina B Oakley; R L Dellacà; Peter A Dargaville; Peter G Davis; Vera Ignjatovic; David G Tingay
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

7.  Antithrombin deficiency is associated with mortality and impaired organ function in septic pediatric patients: a retrospective study.

Authors:  Christian Niederwanger; Tobias Hell; Sophie Hofer; Christina Salvador; Miriam Michel; Bettina Schenk; Benedikt Treml; Mirjam Bachler
Journal:  PeerJ       Date:  2018-09-05       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.